Rita Pimenta

Almada, Portugal

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

Correction: Bridging the Gap in Chronic Prurigo Care: Evidence-Based Diagnostic and Therapeutic Recommendations from a Delphi Consensus Panel.

Correction: Bridging the Gap in Chronic Prurigo Care: Evidence-Based Diagnostic and Therapeutic Recommendations from a Delphi Consensus Panel.

Journal: Dermatology and therapy
Published: August 11, 2026

Complete clearance of high-impact sites with risankizumab in patients with psoriasis: a 2-year real-world retrospective multicenter cohort study.

Complete clearance of high-impact sites with risankizumab in patients with psoriasis: a 2-year real-world retrospective multicenter cohort study.

Journal: The Journal of dermatological treatment
Published: May 06, 2026

Bridging the Gap in Chronic Prurigo Care: Evidence-Based Diagnostic and Therapeutic Recommendations from a Delphi Consensus Panel.

Bridging the Gap in Chronic Prurigo Care: Evidence-Based Diagnostic and Therapeutic Recommendations from a Delphi Consensus Panel.

Journal: Dermatology and therapy
Published: March 06, 2026

Risankizumab super responders in moderate-to-severe psoriasis: prevalence, predictors, and long-term maintenance in a multicenter, international, real-world cohort.

Risankizumab super responders in moderate-to-severe psoriasis: prevalence, predictors, and long-term maintenance in a multicenter, international, real-world cohort.

Journal: The Journal of dermatological treatment
Published: January 23, 2026

Patient Satisfaction Using Guselkumab Self-administered Using the One-Press Device for Treatment of Moderate-to-Severe Psoriasis: Results from a National, Prospective, Real-World Study in Portugal (CERES Study).

Patient Satisfaction Using Guselkumab Self-administered Using the One-Press Device for Treatment of Moderate-to-Severe Psoriasis: Results from a National, Prospective, Real-World Study in Portugal (CERES Study).

Journal: Dermatology and therapy
Published: December 19, 2025

Real-World Evidence on Dose Spacing of Risankizumab for Psoriasis: A Multicenter Retrospective Cohort Study.

Real-World Evidence on Dose Spacing of Risankizumab for Psoriasis: A Multicenter Retrospective Cohort Study.

Journal: Dermatology and therapy
Published: October 07, 2025

Risankizumab in Patients with Psoriasis with Current or Previous Malignancy: A Multicenter, Retrospective Real-World Study.

Risankizumab in Patients with Psoriasis with Current or Previous Malignancy: A Multicenter, Retrospective Real-World Study.

Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: September 17, 2025

Type V aplasia cutis congenita.

Type V aplasia cutis congenita.

Journal: BMJ case reports
Published: August 25, 2025

Real-World Effectiveness, Safety, and Drug Survival of Risankizumab in Adult Patients with Plaque Psoriasis: A 3-Year Multicenter Retrospective Cohort Study.

Real-World Effectiveness, Safety, and Drug Survival of Risankizumab in Adult Patients with Plaque Psoriasis: A 3-Year Multicenter Retrospective Cohort Study.

Journal: American journal of clinical dermatology
Published: May 06, 2025

Treatment of Scabies Using Ivermectin in Children Under 15 kg: A Safe and Effective Option

Treatment of Scabies Using Ivermectin in Children Under 15 kg: A Safe and Effective Option

Journal: Acta medica portuguesa
Published: April 09, 2025

Dupilumab-associated facial and neck dermatitis successfully treated with baricitinib.

Dupilumab-associated facial and neck dermatitis successfully treated with baricitinib.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: March 07, 2023

Myositis Multidisciplinary Clinic in a Tertiary Referral Center.

Myositis Multidisciplinary Clinic in a Tertiary Referral Center.

Journal: Journal of multidisciplinary healthcare
Published: January 08, 2023
Showing 1-12 of 25

Last Updated: 09/26/2026